Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-01-07

Clinical Trial Update: Propranolol in Post Traumatic Stress Disorder [Phase 2]

View source ↗

Summary

A Phase 2 trial of propranolol for Post-Traumatic Stress Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propranolol (propranolol)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Post-Traumatic Stress Disorder | Phase 2 | Status: COMPLETED